Rheumatology International

, Volume 33, Issue 2, pp 341–346 | Cite as

Relationship between sonographic parameters and YKL-40 levels in rheumatoid arthritis

  • Maria Kazakova
  • Anastas Batalov
  • Tanya Deneva
  • Nonka Mateva
  • Zlatimir Kolarov
  • Victoria Sarafian
Original Article


YKL-40, also known as human cartilage glycoprotein 39, is a member of the “mammalian chitinase-like proteins” family without chitinase activity. Increased serum concentrations are associated with inflammatory processes and several types of cancer. In this study, we evaluated YKL-40 levels in serum and synovial fluid of patients with rheumatoid arthritis in comparison with the ultrasonographic findings. YKL-40 levels were measured by enzyme-linked immunosorbent assay in 25 patients with active rheumatoid arthritis and in 40 healthy subjects. B mode and power Doppler were performed to determine synovial thickening and vascularization. Serum YKL-40 level in patients was significantly higher than the concentration in healthy controls (P < 0.01). In patients with rheumatoid arthritis, the level of the glycoprotein in synovial fluid was remarkably elevated compared to the serum level (P = 0.003). The B mode and power Doppler scores correlated to YKL-40 in serum and synovial fluid (P = 0.07). Serum YKL-40 levels were related positively to serum markers of inflammation such as C-reactive protein (P = 0.004) and erythrocyte sedimentation rate (P = 0.003). This study is the first to demonstrate a relationship between YKL-40 levels and ultrasonographic examinations in Bulgarian patients with rheumatoid arthritis. The findings suggest that YKL-40 might be implicated in the pathogenesis of the disease and could indicate the level of joint inflammation.


Joint sonography YKL-40 Rheumatoid arthritis 



The study was supported by grants no. 1/2009 and 1/2010 from Medical University-Plovdiv.


  1. 1.
    Johansen JS (2006) Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 53:172–209PubMedGoogle Scholar
  2. 2.
    Rehli M, Krause SW, Andreesen R (1997) Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 43:221–225PubMedCrossRefGoogle Scholar
  3. 3.
    Roslind A, Johansen JS (2009) YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Methods Mol Biol 511:159–184PubMedCrossRefGoogle Scholar
  4. 4.
    Bojesen SE, Johansen JS, Nostegaard BG (2011) Plasma YKL-40 levels in healthy subjects from the general population. Clin Chim Acta 412:709–712PubMedCrossRefGoogle Scholar
  5. 5.
    Güngen G, Ardic F, Fιndıkoğlu G, Rota S (2011) The effect of mud pack therapy on serum YKL-40 and hsCRP levels in patients with knee osteoarthritis. Rheumatol Int 31:1–10CrossRefGoogle Scholar
  6. 6.
    Zyvanovic S, Rackov LP, Vojvodic D, Vucetic D (2009) Human cartilage glycoprotein 39-biomarker of joint damage in knee osteoarthritis. Int Orthop 33:1165–1170CrossRefGoogle Scholar
  7. 7.
    Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sørensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B (2010) Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 211:589–595PubMedCrossRefGoogle Scholar
  8. 8.
    Letuve S, Kozhich A, Arouche N, Grandsaigne M, Reed J, Dombret MC, Kiener PA, Aubier M, Coyle AJ, Pretolani M (2008) YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol 181:5167–5173PubMedGoogle Scholar
  9. 9.
    Rondbjerg A, Omerovic E, Vestergaard H (2011) YKL-40 levels are independently associated with albuminuria in type 2. Cardiovasc Diabetol 10:54. doi: 10.1186/1475-2840-10-54 PubMedCrossRefGoogle Scholar
  10. 10.
    Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ (2002) High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer 95:267–274PubMedCrossRefGoogle Scholar
  11. 11.
    Yamac D, Ozturk B, Coskun U, Tekin E, Sancak B, Yildiz R, Atalay C (2008) Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer. Adv Ther 25:801–809. doi: 10.1007/s12325-008-0082-2 PubMedCrossRefGoogle Scholar
  12. 12.
    Hogdall E, Johansen JS (2009) YKL-40 tissue expression and plasma levels in patients with ovarian cancer. Biomed Central Cancer 9:8. doi: 10.1186/1471-2407-9-8 PubMedGoogle Scholar
  13. 13.
    Kucur M, Isman FK, Balci C, Onal B, Hacibekiroglu M, Ozkan F, Ozkan A (2008) Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol Oncol 26:47–52PubMedCrossRefGoogle Scholar
  14. 14.
    Tanwar MK, Gilbert MR, Holland EC (2002) Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 62:4364–4368PubMedGoogle Scholar
  15. 15.
    Peltomaa R, Paimela L, Harvey S, Helve T, Leirisalo-Repo M (2001) Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new biomarker for disease activity. Rheumatol Int 20:192–196PubMedCrossRefGoogle Scholar
  16. 16.
    Mandl P, Naredo E, Wakefield RG, Conaghan PG, D’agostino MA, OMERACT Ultrasound Task Force (2011) A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis according to the OMERACT filter. J Rheumatol 38:2055–2062PubMedCrossRefGoogle Scholar
  17. 17.
    Schmidt WA, Schmidt H, Schicke B, Cromlica-Ichle E (2004) Standard reference values for musculoskeletal ultrasonography. Ann Rheum Dis 63:988–994PubMedCrossRefGoogle Scholar
  18. 18.
    Wakefield RJ, Gibbon WW, Conaghan PG, O’Connor P, McGonagle D, Pease C, Green MJ, Veale DJ, Isaacs JD, Emery P (2000) The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 43:2762–2770PubMedCrossRefGoogle Scholar
  19. 19.
    Naredo E, Bonilla G, Gamero F (2005) Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical avaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis 64:375–381PubMedCrossRefGoogle Scholar
  20. 20.
    Fox DA (1997) The role of T cells in the immunopathogenesis of rheumatoid arthritis. New perspectives. Arthritis Rheum 40:598–609PubMedCrossRefGoogle Scholar
  21. 21.
    Emery P, Gough A, Salmon M, Devlin J (1993) Medical management of rheumatoid arthritis. BMJ 307:425–428CrossRefGoogle Scholar
  22. 22.
    Kirwan JR, Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 333:142–147PubMedCrossRefGoogle Scholar
  23. 23.
    Johansen JS, Jensen HS, Price PA (1993) A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 32:949–955PubMedCrossRefGoogle Scholar
  24. 24.
    Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Østergaard M, Østergaard K, Løvgreen-Nielsen P, Sonne-Holm S, Lorenzen I (2001) Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthr Cartil 9:203–214PubMedCrossRefGoogle Scholar
  25. 25.
    Knudsen LS, Hetland ML, Johansen JS, Skjodt H, Peters ND, Colic A, Grau K, Nielsen NJ, Ostergaard M (2009) Changes in plasma IL-6, plasma VEGF and serum YKL-40 during treatment with etanercept and methotrexate or etanercept alone in patients with active rheumatoid arthritis despite methotrexate therapy. Biomarker Insights 4:91–95PubMedGoogle Scholar
  26. 26.
    Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M (1997) Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 237:46–54PubMedCrossRefGoogle Scholar
  27. 27.
    Volck B, Price PA, Johansen JS, Sørensen O, Benfield T, Calafat J, Nielsen HJ, Borregaard N (1998) YKL-40, a mammalian member of the bacterial chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Phys 110:351–360PubMedGoogle Scholar
  28. 28.
    Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268:25803–25810PubMedGoogle Scholar
  29. 29.
    Takahashi M, Naito K, Abe M, Sawada T, Nagano A (2004) Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 6:208–212CrossRefGoogle Scholar
  30. 30.
    Syversen SW, Goll GL, Heijde D, Landeve R, Lie BA, Odegard S, Uhlig T, Gaarder PI, Kvien TK (2009) Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis 69:345–351. doi: 10.1136/ard.2009.113092 PubMedCrossRefGoogle Scholar
  31. 31.
    Weidekamm C, Koller M, Weber M, Kainberger F (2003) Diagnostic value of high-resolution B-mode and Doppler sonography for imaging of hand and finger joints in rheumatoid arthritis. Arthritis Rheum 48:325–333PubMedCrossRefGoogle Scholar
  32. 32.
    Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, Yan W, Bentley B, Shao R (2011) Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem 286:15332–15343PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Maria Kazakova
    • 1
  • Anastas Batalov
    • 2
  • Tanya Deneva
    • 3
  • Nonka Mateva
    • 4
  • Zlatimir Kolarov
    • 5
  • Victoria Sarafian
    • 1
  1. 1.Department of Medical BiologyMedical University-PlovdivPlovdivBulgaria
  2. 2.Department of RheumatologyMedical University-PlovdivPlovdivBulgaria
  3. 3.Department of Clinical LaboratoryMedical University-PlovdivPlovdivBulgaria
  4. 4.Department of Health Management, Health Economics and General MedicineMedical University-PlovdivPlovdivBulgaria
  5. 5.Clinic of RheumatologyMedical University-SofiaSofiaBulgaria

Personalised recommendations